MBRX

Moleculin Biotech Inc

Jun 04 • 04:00PM ET

2.51

+0.05 2.03 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BLRX CYCN ERNA GDTC GNTA GTBP ICU INTS RKTO TOVX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-28.04	Insider Own	0.83%	Shs Outstand	5.34M	Perf Week	-8.39%
Market Cap	13.39M	Forward P/E	-	EPS next Y	-3.84	Insider Trans	0.00%	Shs Float	5.29M	Perf Month	0.80%
Enterprise Value	3.40M	PEG	-	EPS next Q	-1.54	Inst Own	3.21%	Short Float	9.98%	Perf Quarter	12.05%
Income	-32.20M	P/S	-	EPS this Y	82.01%	Inst Trans	1.13%	Short Ratio	3.03	Perf Half Y	-62.14%
Sales	0.00M	P/B	0.88	EPS next Y	24.84%	ROA	-136.70%	Short Interest	0.53M	Perf YTD	-24.17%
Book/sh	2.85	P/C	1.30	EPS next 5Y	49.99%	ROE	-398.45%	52W High	24.00 -89.54%	Perf Year	-85.09%
Cash/sh	1.93	P/FCF	-	EPS past 3/5Y	57.89% 46.71%	ROIC	-197.37%	52W Low	1.79 40.22%	Perf 3Y	-98.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.92% 8.46%	Perf 5Y	-99.82%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.65%	Oper. Margin	-	ATR (14)	0.20	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	1.38	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.66	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.38	EPS Q/Q	79.43%	SMA20	3.44%	Beta	1.77	Target Price	21.00
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	2.39%	Rel Volume	1.54	Prev Close	2.46
Employees	17	LT Debt/Eq	0.01	Earnings	May 15 BMO	SMA200	-59.66%	Avg Volume	173.94K	Price	2.51
IPO	Jun 02, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	-51.72% -	Trades		Volume	267,088	Change	2.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)